logo
Plus   Neg
Share
Email

PayPal To Waive Certain Fees, Deferring Repayments Amid COVID-19 - Quick Facts

PayPal Holdings, Inc. (PYPL) announced Tuesday a set of relief measures to help its more than 24 million merchants around the world impacted by the coronavirus (COVID-19) pandemic.

The company said it is waiving certain fees and will be deferring repayments on business loans for some of its most affected small business customers.

PayPal is waiving chargeback fees for merchants if their customer files a dispute with a credit card issuer through at least April 30, 2020. It is also extending the window in which merchants must respond to a customer dispute from 10 to 20 days through at least April 30, 2020.

It is waiving fees to instantly withdraw money from a PayPal business account to a bank account, Mastercard Debit or Visa Debit card through at least April 30, 2020.

Additionally, PayPal is doubling the instant cash back reward on eligible purchases beginning April 1 through at least April 30, 2020 in partnership with Mastercard.

"We are taking immediate steps to help our small business customers who are most impacted by the coronavirus pandemic to help them navigate these challenging times," said Dan Schulman, president and CEO, PayPal.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
RELATED NEWS
Follow RTT